To investigate the relationship between clinical characteristics and ADH1B expression, we divided ovarian cancer patients into two groups with high and low ADH1B expression and performed statistical analysis using the clinical data from the TCGA database. This evidence concerns the gene ADH1B and ovarian carcinoma.